| Literature DB >> 36071903 |
Jiaodan Yu1, Yi Wan1, Jieli Zhao1, Ruonan Huang1, Peixia Wu1,2, Wenyan Li1,3,4,5.
Abstract
Objective: Rotational Chair Test (RCT) is considered one of the most critical measures for vestibular functionality, which generally includes the sinusoidal harmonic acceleration test (SHAT), velocity step test (VST), and visual suppression (VS). The purpose of this study was to establish normal values for different age groups on the RCT and investigate whether motion susceptibility, such as with a history of motion sickness or migraine, has any effects on test metrics.Entities:
Keywords: motion sickness (MS); rotational chair test; sinusoidal harmonic acceleration test (SHAT); velocity step test (VST); velocity storage mechanism (VSM); visual suppression (VS)
Year: 2022 PMID: 36071903 PMCID: PMC9441918 DOI: 10.3389/fneur.2022.978442
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Demographics of the subjects.
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| 20–29 | 22 | 25.86 ± 2.47 | 9 (41) | 13 (49) |
| 30–39 | 13 | 33.77 ± 2.20 | 8 (62) | 5 (38) |
| 40–49 | 24 | 45.13 ± 3.22 | 11 (46) | 13 (54) |
| 50–59 | 18 | 54.06 ± 2.71 | 5 (28) | 13 (72) |
| Total | 77 | 39.79 ± 11.26 | 33 (43) | 44 (57) |
Demographics of the four groups.
|
|
|
|
|
|
|---|---|---|---|---|
| Motion sickness | 13/109 | 29.62 ± 9.32 | 3 | 10 |
| Migraine | 8/109 | 33.13 ± 10.32 | 2 | 6 |
| Comorbidity | 11/109 | 27.73 ± 4.54 | 4 | 7 |
| Control | 77/109 | 39.79 ± 11.26 | 33 | 44 |
Comorbidity group indicated the subjects have both migraine and motion sickness.
SHAT normative values of four age groups.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| 0.01 | Gain | 0.30 ± 0.08 | 0.27 ± 0.11 | 0.36 ± 0.14 | 0.38 ± 0.12 | 0.044 |
| Phase | −44.86 ± 5.84 | −45.08 ± 5.54 | −41.62 ± 7.22 | −43.81 ± 7.48 | 0.324 | |
| Asymmetry | 10.48 ± 10.78 | 12.46 ± 14.05 | 2.42 ± 12.16 | 4.19 ± 9.53 | 0.031 | |
| 0.02 | Gain | 0.37 ± 0.13 | 0.35 ± 0.14 | 0.42 ± 0.14 | 0.43 ± 0.12 | 0.189 |
| Phase | −26.86 ± 7.89 | −24.69 ± 4.77 | −21.87 ± 5.61 | −24.20 ± 4.09 | 0.056 | |
| Asymmetry | 3.82 ± 9.45 | 3.69 ± 11.29 | 1.50 ± 12.36 | −1.80 ± 7.13 | 0.392 | |
| 0.04 | Gain | 0.44 ± 0.14 | 0.43 ± 0.14 | 0.47 ± 0.15 | 0.48 ± 0.12 | 0.395 |
| Phase | −11.95 ± 8.79 | −13.00 ± 3.52 | −13.46 ± 6.18 | −14.50 ± 4.26 | 0.682 | |
|
| (−3.00, 6.50) | (−2.00, 18.00) | (−8.75, 9.75) | (−2.75, 8.00) | 0.545 | |
| 0.08 | Gain | 0.47 ± 0.15 | 0.41 ± 0.11 | 0.46 ± 0.17 | 0.54 ± 0.14 | 0.134 |
| Phase | −3.90 ± 4.92 | −4.54 ± 4.43 | −2.54 ± 7.09 | −8.12 ± 4.29 | 0.019 | |
| Asymmetry | 2.48 ± 10.23 | 3.23 ± 10.13 | 0.92 ± 9.82 | −0.18 ± 8.52 | 0.749 | |
| 0.16 | Gain | 0.47 ± 0.19 | 0.42 ± 0.11 | 0.47 ± 0.20 | 0.51 ± 0.15 | 0.614 |
|
| (−5.50, 4.00) | (−0.75, 9.50) | (−6.00, 2.00) | (−11.50, −1.75) | 0.001 | |
|
| (−4.00, 11.50) | (0.25, 15.50) | (−13.00, 8.00) | (−9.25, 5.00) | 0.013 | |
| 0.32 | Gain | 0.54 ± 0.21 | 0.51 ± 0.17 | 0.48 ± 0.20 | 0.52 ± 0.19 | 0.539 |
|
| (−2.75, 2.75) | (−5.50, 5.00) | (−16.25, −0.75) | (−17.25, −5.50) | <0.001 | |
|
| (−4.00, 6.75) | (−1.25, 8.50) | (−5.00, 7.00) | (−7.25, 3.25) | 0.235 | |
| 0.64 | Gain | 0.69 ± 0.19 | 0.62 ± 0.20 | 0.63 ± 0.21 | 0.69 ± 0.14 | 0.520 |
|
| (−8.00, 0.00) | (−6.50, 1.00) | (−29.00, −3.00) | (−37.00, −12.00) | <0.001 | |
| Asymmetry | 3.81 ± 8.38 | 6.00 ± 6.71 | −0.62 ± 6.83 | −2.72 ± 7.14 | 0.005 | |
Bold fonts indicate that data of parameters were presented as Inter Quartile Range.
Statistically significant according to Kruskal-Wallis test or one-way ANOVA (p < 0.05).
Figure 1Comparison of the phase across MS group, migraine group, comorbidity group and control group for each frequency by multiple-factors ANOVA. Corrected phase values are presented by mean and standard error. The asterisk (*) indicates a significant difference exists.
Comparison for velocity step test for the control group, motion sickness group, migraine group, and comorbidity group.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| CW | Post-rotary gain | 0.63 ± 0.13 | 0.57 ± 0.18 | 0.68 ± 0.12 | 0.73 ± 0.18 | 0.060 |
| TC | 14.33 ± 3.96 | 14.51 ± 5.06 | 14.15 ± 3.73 | 14.90 ± 4.96 | 0.976 | |
| CCW | Post-rotary gain | 0.62 ± 0.15 | 0.57 ± 0.14 | 0.62 ± 0.10 | 0.69 ± 0.12 | 0.317 |
| TC | 14.85 ± 3.75 | 12.10 ± 4.21 | 14.39 ± 4.85 | 14.46 ± 4.32 | 0.330 |
MS, motion sickness; CW, clock-wise; CCW, counter clock-wise; TC, time constant.